Skip to main content

and
  1. No Access

    Article

    The obesity paradox in heart failure patients with preserved versus reduced ejection fraction: a meta-analysis of individual patient data

    In heart failure (HF), obesity, defined as body mass index (BMI) ⩾30 kg m−2, is paradoxically associated with higher survival rates compared with normal-weight patients (the ‘obesity paradox’). We sought to deter...

    R Padwal, F A McAlister, J J V McMurray, M R Cowie in International Journal of Obesity (2014)

  2. No Access

    Article

    Multicomponent, home-based resistance training for obese adults with type 2 diabetes: a randomized controlled trial

    To investigate whether a home-based resistance training (RT) program that supplied high-quality equipment and qualified exercise specialists could provide benefits to obese patients with type 2 diabetes.

    R C Plotnikoff, N Eves, M Jung, R J Sigal, R Padwal in International Journal of Obesity (2010)

  3. No Access

    Article

    Association between obesity and health-related quality of life in patients with coronary artery disease

    In patients with coronary artery disease (CAD), obesity is paradoxically associated with better survival (the ‘obesity paradox’). Our objective was to determine whether this counterintuitive relationship exten...

    A Oreopoulos, R Padwal, F A McAlister, J Ezekowitz in International Journal of Obesity (2010)

  4. No Access

    Article

    Long-term persistence with orlistat and sibutramine in a population-based cohort

    Orlistat and sibutramine are widely prescribed antiobesity agents that are approved for 2 years of continuous use. Previous 1–4-year randomized, placebo-controlled trials of these drugs have reported average w...

    R Padwal, A Kezouh, M Levine, M Etminan in International Journal of Obesity (2007)

  5. No Access

    Article

    Long-term pharmacotherapy for overweight and obesity: a systematic review and meta-analysis of randomized controlled trials

    CONTEXT: Safe and effective strategies to curb rising obesity prevalence rates are urgently needed and medications may play a more prominent role in future therapeutic regimens.

    R Padwal, S K Li, D C W Lau in International Journal of Obesity (2003)